Latest News

• Drug Companies Greet 2019 With U.S. Price Hikes Drugmakers kicked off 2019 with price increases in the United States on more than 250 prescription drugs, including the world's top-selling medicine, Humira, although the pace of price hikes was slower than last year.
  Reuters Health Information, January 2019
• European Nations Weigh Impact of Brexit on Drug Supplies Germany's drug safety regulator has concluded that Brexit will not put its patients at risk of losing access to essential drugs, while Ireland has drawn up a list of 24 medicines whose supply would be most vulnerable if Britain fails to conclude a divorce deal.
  Reuters Health Information, January 2019
• Gay Fathers Face Stigma as Parents Even as parenting by same-sex couples becomes more common in the U.S., many gay men and their families still experience discrimination and are stigmatized by relatives, neighbors, salespeople and other members of their communities, a study suggests.
  Reuters Health Information, January 2019
• Fecal-Microbiota Transplant Beats Antibiotics for Recurrent C Diff Fecal-microbiota transplantation (FMT) is superior to 10 days of fidaxomicin or vancomycin for resolving recurrent Clostridium difficile infection (CDI), according to results from a randomized open-label clinical trial.
  Reuters Health Information, January 2019
• Endoscopic Transvesical Adenomectomy Allows Less-Invasive Treatment of Large BPH Endoscopic transvesical adenomectomy of the prostate (ETAP) provides a less-invasive alternative for treating large benign prostatic hyperplasia (BPH), researchers from the Netherlands report.
  Reuters Health Information, January 2019
• Nef Gene Function and HIV Subtype Influence Viral Reservoir Size In patients with HIV, the size of the viral reservoir depends, at least in part, on their HIV subtype and the level of Nef gene activity, researchers say.
  Reuters Health Information, January 2019
• Thyroidectomy Outcomes Comparable With Remote Access or Transcervical Approaches Remote-access approaches (RAA) to thyroidectomy provide outcomes comparable to those performed via an anterior cervical incision, according to a new review.
  Reuters Health Information, January 2019
• Cyclosporine Emulsion Promising in Vernal Keratoconjunctivitis Cyclosporine A cationic emulsion (CsA CE) appears more effective than vehicle alone in treating pediatric patients with vernal keratoconjunctivitis, according to a study funded by the developer, Santen.
  Reuters Health Information, January 2019
• U.N. Delivers Food for 9.5 Million in Yemen Last Month, Shy of Target The U.N. food agency delivered emergency food and vouchers for over 9.5 million people in Yemen in December, just shy of its 10 million monthly target in the famine-threatened country, a spokesman said on Tuesday.
  Reuters Health Information, January 2019
• Intoxication From Synthetic-Cannabinoid-Receptor Agonists Often Missed Nearly half of patients with suspected synthetic-cannabinoid-receptor agonist (SCRA) intoxication test negative for an SCRA, and many test positive for another substance, researchers report.
  Reuters Health Information, January 2019
• United Health Fourth-Quarter Profit Beats on Optum Strength UnitedHealth Group Inc beat Wall Street estimates for fourth-quarter profit on Tuesday, mainly driven by growth in its services business, including its pharmacy benefits unit.
  Reuters Health Information, January 2019
• Australian Authorities Warn About Heat as Temperature Soars Australians have been warned to avoid exerting themselves outdoors and to drink lots of water as record temperatures in parts of the country look set to linger, and even increase, over coming days.
  Reuters Health Information, January 2019
• French Court Cancels Monsanto Weedkiller Permit on Safety Grounds A French court canceled the license for one of Monsanto's glyphosate-based weedkillers on Tuesday over safety concerns, in the latest blow to the Bayer-owned business.
  Reuters Health Information, January 2019
• Short Supply, Cost of Key Drugs Leave Hospitals Scrambling Hospital groups called for legislation to speed the introduction of generic medicines, seeking more competition to address concerns about cost and supply.
  Medscape Medical News, January 2019
• Single-Dose Drug Prevents Malaria Relapse Data from two phase 3 trials show the efficacy of single-dose tafenoquine in preventing malarial relapse but underscore the need for appropriate patient selection.
  Medscape Medical News, January 2019
• Fewer Uninsured but Similar MI Outcomes With Medicaid Expansion Medicaid eligibility expansion was associated with a reduction in uninsured patients reporting to hospital with an acute myocardial infarction, but not with improved outcomes.
  Medscape Medical News, January 2019
• Alert FDA Clears First Generic Version of Seizure Drug Sabril Generic vigabatrin is indicated as add-on therapy for the treatment of complex partial seizures in patients aged 10 and older who are refractory to several other treatments.
  FDA Approvals, January 2019
• Clinical Trials Too Often Exclude 'Real-World' Cancer Patients Restrictive clinical trial criteria frequently exclude patients with comorbidities from important cancer studies, but such patients might benefit from the treatment being study.
  Medscape Medical News, January 2019
• Cardiometabolic Risks Increased With Tourette, Tic Disorders The increased risk for disorders such as diabetes and obesity begins in childhood and is higher in those with concomitant ADHD.
  Medscape Medical News, January 2019
• Shutdown Starting to Delay New FDA Reviews, Approvals The FDA is relying on industry-paid user fees and is shifting resources to keep itself partially open.
  Medscape Medical News, January 2019